Strategies for designing antibody-toxin conjugates
- 1 October 1988
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 6 (10), 246-251
- https://doi.org/10.1016/0167-7799(88)90056-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- New Indirect Approach to the Therapeutic Use of ImmunotoxinsJNCI Journal of the National Cancer Institute, 1988
- Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin SelectivityScience, 1987
- Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coliCell, 1987
- Immunotoxins Containing Ricin A Or B Chains with Modified Carbohydrate Residues Act Synergistically in Killing Neoplastic B CellsIn Vitro*Cancer Drug Delivery, 1985
- Blockade of the galactose‐binding sites of ricin by its linkage to antibodyEuropean Journal of Biochemistry, 1984
- Antibody formation against the cytotoxic proteins abrin and ricin in humans and miceInternational Journal of Cancer, 1983
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982
- The Preparation and Cytotoxic Properties of Antibody‐Toxin ConjugatesImmunological Reviews, 1982
- A comparison of the accumulation of ricin by hepatic parenchymal and non-parenchymal cells and its inhibition of protein synthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975